LifeMD to Expand Affordable Access to Wegovy® for Cash-Pay Patients

  LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announced plans to offer broad, affordable, and streamlined access to Wegovy® (semaglutide) through NovoCare® Pharmacy. This integration offers a simplified pathway for cash-pay patients to access all FDA-approved dose strengths of Wegovy® directly within LifeMD’s virtual care platform.

LifeMD’s weight management program is one of the fastest-growing cash-pay offerings in the country, delivering virtual consultations, lab testing, diet and lifestyle support, and prescriptions to anti-obesity medications including GLP-1s when clinically appropriate, within a single, tech-enabled platform. The addition of direct access to Wegovy® through NovoCare® Pharmacy enhances LifeMD’s ability to support patients with a brand-name GLP-1 option at a recently reduced self-pay cost of $499 per month, including convenient home delivery.

“Working with NovoCare® Pharmacy represents a meaningful step forward for LifeMD’s weight management program,” said Justin Schreiber, Chairman and CEO of LifeMD. “By embedding direct access to Wegovy® via NovoCare® Pharmacy into our platform, we’re enhancing the patient experience, expanding access to a critical medication, and reinforcing LifeMD’s position as a leader in delivering comprehensive, technology-enabled obesity care. With this offering, we’ve taken another important step in delivering on our promise of reducing friction in the patient journey—ensuring more patients can access life-changing medications like Wegovy® without unnecessary delays or barriers.”

This offering reflects the growing demand among cash-pay patients for convenient access to clinically backed FDA-approved obesity treatment options. With an end-to-end digital care experience and vertically integrated infrastructure—including a 50-state affiliated medical group and national diagnostic lab partnerships—LifeMD is uniquely positioned to deliver branded GLP-1 therapies at scale.

https://www.globenewswire.com/news-release/2025/04/29/3070180/0/en/LifeMD-Announces-Plans-to-Expand-Affordable-Access-to-Wegovy-for-Cash-Pay-Patients.html